AXQ Capital’s Immunogen Inc IMGN Stock Holding History

AXQ Capital’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-13,000	Closed	-$206K	–	844
2023 Q3	$206K	Buy	+13,000	New	+$216K	0.07%	385
2023 Q1	–	Sell	-27,336	Closed	-$136K	–	671
2022 Q4	$136K	Buy	+27,336	New	+$148K	0.09%	288

Other funds holding IMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

AXQ Capital's IMGN Position: Q4 2023 in Review

AXQ Capital sold out of Immunogen Inc (IMGN) in Q4 2023, closing a stake of 13,000 shares — an estimated $206K sold.

AXQ Capital first reported a position in IMGN in Q4 2022 and held it in 2 quarters. The position peaked at $206K in Q3 2023. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.

AXQ Capital reported no remaining Immunogen Inc position as of Q4 2023 after selling out during the quarter.
AXQ Capital sold 13,000 Immunogen Inc shares in Q4 2023, an estimated $206K.
AXQ Capital first reported a position in Immunogen Inc in Q4 2022 and held it in 2 quarters.
AXQ Capital's Immunogen Inc position peaked at $206K in Q3 2023.
327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.

Based on AXQ Capital's 13F filing for Q4 2023, filed 13 Feb 2024.